The stock of GSK Plc ADR (NYSE:GSK) last traded at $37.50, up 1.27% from the previous session.
GSK stock price is now -0.17% away from the 50-day moving average and -0.51% away from the 200-day moving average. The market capitalization of the company currently stands at $75.97B.
With the price target of $35.25, Exane BNP Paribas recently initiated with Neutral rating for GSK Plc ADR (NYSE: GSK). , while ‘Deutsche Bank’ rates the stock as ‘Hold’
In other news, GSK plc, 10% Owner bought 2,791,930 shares of the company’s stock on Sep 27 ’24. The stock was bought for $22,335,440 at an average price of $8.00. Upon completion of the transaction, the 10% Owner now directly owns 16,775,691 shares in the company, valued at $629.09 million. A total of 0.00% of the company’s stock is owned by insiders.
During the past 12 months, GSK Plc ADR has had a low of $31.72 and a high of $45.92. As of last week, the company has a debt-to-equity ratio of 1.24, a current ratio of 0.78, and a quick ratio of 0.52. According to the stock market information, the enterprise value for the company is $165105664000, which is based on a 23.70 price-to-earnings ratio, a 2.80 price-to-earnings-growth ratio, and a beta of 0.53. The fifty day moving average price for GSK is $37.564 and a two-hundred day moving average price translates $37.69335 for the stock.
The latest earnings results from GSK Plc ADR (NYSE: GSK) was released for 2024-12-31. The net profit margin was 8.13% and return on equity was 19.11% for GSK. The company reported revenue of $10.39 billion for the quarter, compared to $9.98 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 4.08 percent. For the current quarter, analysts expect GSK to generate $7.46B in revenue.
